R&D
A global pioneer in the development of new drugs
SK Biopharmaceuticals’ ongoing research is
continuously presented at esteemed international events.

-
83921 AES 2024 Broad Spectrum abs_2024-06-04
-
83922 AES 2024 RNS Study abstract_2024-06-06v4
-
83928 AES 2024 MOA abs_2024-05-31
-
83930 AES 2024 C035 primary abs_2024_06-10
-
83931 AES 2024 C035 Early Response Abs_2024-06-07
-
83932 AES 2024 C035 Seizure Subtype Abs_2024-06-06
-
83952 Rosenfeld AES 2024 SF dose abs_FINAL
-
83959 AES 2024 Truveta effective dose abstract_2024-06-05
-
83960 AES 2024 LGS PK abstract 2024-06-05
-
Crumb AES 2024 abstract_2024-06-06v2
-
1.400 Misra AES poster_2024-11-15v1
-
1.403 Vashi AES 2024 poster_2024-10-24v1
-
1.404 Pradhan AES poster 2024-11-07v1
-
1.405 Ferrari AES 2024 poster_2024-11-01v2
-
1.425 Sachdeo AES Poster 2024-11-12v1
-
1.436 Wade AES poster_2024-11-07v1
-
1.437 Sankar AES MOA poster 2024-11-08v1
-
2.378 Rosenfeld AES 2024 poster_2024-10-24v1
-
2.412 Melnick AES poster_2024-11-06v1
-
3.329 Connor AES poster 2024-11-18v1
-
84016 AES RNS Study Presentation 2024-11-19v1
-
84018 Crumb AES Cardiac Arrythmias 2024-11-21v1